Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4

Summary: The adenoviral vector-based AstraZeneca and Janssen COVID-19 vaccines have been associated with rare cases of thrombosis, believed to be triggered, among other factors, by vector binding to the blood protein platelet factor 4 (PF4). To identify vectors with lower thrombosis risk, we screene...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Erwan Sallard, Daniel Pembaur, Matias Ciancaglini, Lucie Manov-Bouard, Denice Weklak, Firas Hamdan, Chun Kit Chan, Franziska Jönsson, Elise Chabot, Carmen Musielak, Elena Scurti, Sara Feola, Sebastian Schellhorn, Nissai Beaude, Katrin Schröer, Daipayan Sarkar, Georgia Koukou, Xiaoyan Wang, Natascha Schmidt, Wibke Bayer, Malik Aydin, Vera Kemp, Alan L. Parker, Dirk Grimm, Tapani Viitala, Vincenzo Cerullo, Abhishek Singharoy, Alexander T. Baker, Wenli Zhang, Daniel Pinschewer, Florian Kreppel, Anja Ehrhardt
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-01-01
Цуврал:	iScience
Нөхцлүүд:	Molecular biology Immune response
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2589004225025908
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!